188 results
Page 2 of 10
8-K
EX-99.1
w8xx3bcp 0s
9 Dec 19
Windtree Therapeutics Completes $26.4 Million Private Placement
5:09pm
8-K
EX-99.1
i1on41pgmlh8r5ry 9i
25 Oct 19
Windtree Therapeutics Provides Business Update
5:17pm
8-K
EX-99.1
5s3q84lijm 3ku
14 Aug 19
Windtree Therapeutics Reports Second Quarter 2019 Financial Results and Provides Key Business Updates
12:00am
8-K
EX-99.1
pcjq8xd14hv3
31 May 19
Istaroxime Phase 2b Study Results Presented in Late Breaker Clinical Trial Session at the ESC Heart Failure Congress
4:17pm
8-K
EX-99.1
vvcfk
30 Apr 19
Windtree Therapeutics Appoints Daniel Geffken to Board of Directors
4:26pm
8-K/A
EX-99.1
2yh9x6hf4 ug8ngby
8 Mar 19
Completion of Acquisition or Disposition of Assets
4:24pm
8-K/A
EX-99.2
8dj7un z1abj1x0yldu9
8 Mar 19
Completion of Acquisition or Disposition of Assets
4:24pm
8-K
EX-99.1
rjifhw
21 Dec 18
Windtree Therapeutics and CVie Therapeutics Announce Merger to Create a Global Acute Care Company Targeting Cardiovascular and Respiratory Diseases
5:28pm
8-K
EX-99.1
vvjxtexuq9o19jfvgz7m
24 Jul 18
Windtree Announces Completion of New Design Development for its Aerosol Delivery System (ADS) including Successful Performance Testing
5:01pm
8-K
EX-99.1
rruk71ew6l5209
18 Apr 16
Amendments to Articles of Incorporation or Bylaws
12:00am